Sensitization of adenylate cyclase by Galpha i/o-coupled receptors
- PMID: 15922020
- DOI: 10.1016/j.pharmthera.2004.12.005
Sensitization of adenylate cyclase by Galpha i/o-coupled receptors
Abstract
Activation of receptors coupled to inhibitory G proteins (Galpha i/o) has opposing consequences for cyclic AMP accumulation and the activity of cyclic AMP-dependent protein kinase, depending on the duration of stimulation. Acute activation inhibits the activity of adenylate cyclase, thereby attenuating cyclic AMP accumulation; in contrast, persistent activation of Galpha i/o-coupled receptors produces a paradoxical enhancement of adenylate cyclase activity, thus increasing cyclic AMP accumulation when the action of the inhibitory receptor is terminated. This heterologous sensitization of cyclic AMP signaling, also called superactivation or supersensitization, likely represents a cellular adaptive response, a mechanism by which the cell compensates for chronic inhibitory input. Recent advances in our knowledge of G protein-mediated signaling, regulation of adenylate cyclase, and other cellular signaling mechanisms have extensively increased our insight into the mechanisms and significance of this phenomenon. In particular, recent evidence points to the Galpha(s)-adenylate cyclase interface as a locus for the expression of the sensitized adenylate cyclase response, and to isoform-specific phosphorylation of adenylate cyclase as one mechanism that can produce sensitization. Galpha i/o-coupled receptor-induced heterologous sensitization may contribute to enhanced Galpha(s)-coupled receptor signaling following neurotransmitter elevations induced by the administration of drugs of abuse and during other types of neuronal function or dysfunction. This review will focus on recent advances in our understanding of signaling pathways that are involved in sensitization and describe the potential role of sensitization in neuronal function.
Similar articles
-
Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.J Pharmacol Exp Ther. 2001 Jun;297(3):1201-9. J Pharmacol Exp Ther. 2001. PMID: 11356947
-
Sensitization of adenylate cyclase: a general mechanism of neuroadaptation to persistent activation of Galpha(i/o)-coupled receptors?Life Sci. 2003 Oct 24;73(23):2913-25. doi: 10.1016/s0024-3205(03)00703-3. Life Sci. 2003. PMID: 14519441 Review.
-
Galphaq-coupled receptor signaling enhances adenylate cyclase type 6 activation.Biochem Pharmacol. 2005 Jul 1;70(1):113-20. doi: 10.1016/j.bcp.2005.04.007. Biochem Pharmacol. 2005. PMID: 15885660
-
Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.Methods Enzymol. 2004;389:155-69. doi: 10.1016/S0076-6879(04)89010-4. Methods Enzymol. 2004. PMID: 15313565 Review.
-
D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.Neuropharmacology. 2006 Apr;50(5):576-84. doi: 10.1016/j.neuropharm.2005.11.004. Epub 2005 Dec 27. Neuropharmacology. 2006. PMID: 16376953
Cited by
-
Circuit Analysis of a Drosophila Dopamine Type 2 Receptor That Supports Anesthesia-Resistant Memory.J Neurosci. 2016 Jul 27;36(30):7936-45. doi: 10.1523/JNEUROSCI.4475-15.2016. J Neurosci. 2016. PMID: 27466338 Free PMC article.
-
Differential requirement for protein synthesis in presynaptic unmuting and muting in hippocampal glutamate terminals.PLoS One. 2012;7(12):e51930. doi: 10.1371/journal.pone.0051930. Epub 2012 Dec 13. PLoS One. 2012. PMID: 23272190 Free PMC article.
-
A translocated bacterial protein protects vascular endothelial cells from apoptosis.PLoS Pathog. 2006 Nov;2(11):e115. doi: 10.1371/journal.ppat.0020115. PLoS Pathog. 2006. PMID: 17121462 Free PMC article.
-
New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling.Biochem Pharmacol. 2015 Jan 1;93(1):85-91. doi: 10.1016/j.bcp.2014.10.014. Epub 2014 Nov 7. Biochem Pharmacol. 2015. PMID: 25449598 Free PMC article.
-
Optogenetic activation of heterotrimeric G-proteins by LOV2GIVe, a rationally engineered modular protein.Elife. 2020 Sep 16;9:e60155. doi: 10.7554/eLife.60155. Elife. 2020. PMID: 32936073 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources